Understanding Vaginal Cancer: Symptoms, Causes, and Risk Factors

Vaginal cancer is a rare but serious gynaecological cancer, accounting for a small proportion of cancers affecting the female reproductive system. Because it is uncommon and may not cause noticeable symptoms in its early stages, the disease may go unrecognised, leading to delayed diagnosis in some cases. This makes it important to understand how vaginal cancer may present, who may be at higher risk, and when medical evaluation is needed. To support awareness and timely care, this article outlines the symptoms of vaginal cancer, explains its causes and risk factors, and highlights key factors that influence early detection and appropriate clinical management.

What is Vaginal Cancer?

Vaginal cancer is a type of cancer that develops in the cells lining the vagina, the muscular canal that connects the cervix (lower part of the uterus) to the external genitalia. It occurs when abnormal cells in the vaginal tissue begin to grow and multiply in an uncontrolled manner, forming a tumour.

This cancer is relatively rare compared to other gynaecological cancers and most often affects older women, although it can occur at any age. Vaginal cancer may arise as a primary cancer originating in the vagina or, more commonly, as a spread from cancers of nearby organs such as the cervix, uterus, or vulva. Early stages may cause few or no symptoms, which is why regular gynaecological check-ups and awareness of warning signs are important for early detection.

Types of Vaginal Cancer

Vaginal cancer is classified based on the type of cells in which the cancer begins. Understanding the different types helps explain how the disease may behave and guides further evaluation and treatment planning.

The main types of vaginal cancer include:

• Squamous Cell Carcinoma: This is the most common type of vaginal cancer. It develops from the thin, flat squamous cells that line the surface of the vagina. Squamous cell carcinoma usually grows slowly and is more often diagnosed in older, postmenopausal women.
• Adenocarcinoma: Adenocarcinoma arises from the glandular cells of the vaginal lining. This type is less common and may be seen in younger women, including those with a history of in-utero exposure to diethylstilbestrol (DES).
• Rare Types of Vaginal Cancer: Less commonly, vaginal cancer may develop as melanoma, sarcoma, or other rare forms. These cancers behave differently and often require specialised evaluation and treatment approaches.

Identifying the specific type of vaginal cancer is an important step in determining how the disease is likely to progress and which treatment options may be most appropriate.

Symptoms of Vaginal Cancer

The symptoms of vaginal cancer can vary depending on the stage of the disease and may develop gradually over time. In many cases, early-stage vaginal cancer may not cause noticeable symptoms, which is why changes that persist or appear without a clear cause should be evaluated by a doctor.

Common symptoms of vaginal cancer may include:

• Abnormal vaginal bleeding: This may occur after intercourse, between menstrual periods, or after menopause. Any postmenopausal vaginal bleeding should be assessed promptly.
• Unusual vaginal discharge: Persistent discharge that is watery, blood-stained, or foul-smelling may be a warning sign, particularly if it is not linked to an infection.
• Pelvic pain or pressure: Ongoing discomfort, pressure, or pain in the pelvic area may occur as the disease progresses.
• Pain during intercourse: Discomfort or pain during sexual activity can sometimes be associated with vaginal cancer and should not be ignored if it persists.
• Urinary or bowel changes: In more advanced cases, symptoms such as difficulty urinating, frequent urination, constipation, or blood in the urine or stool may be present due to pressure on nearby organs.

Because these symptoms can also be caused by non-cancerous conditions, their presence does not necessarily indicate cancer. However, timely medical evaluation of persistent or unexplained symptoms is essential for accurate diagnosis and appropriate care.

When to See a Doctor

Not all vaginal symptoms indicate cancer, but certain changes should prompt timely medical evaluation, especially when they persist or occur without an obvious cause. Early consultation allows appropriate investigations to be carried out and helps rule out serious conditions.

You should consider seeing a doctor if you experience:

• Vaginal bleeding after menopause, after intercourse, or between periods
• Persistent or unusual vaginal discharge that does not improve with treatment
• Ongoing pelvic pain or pressure
• Pain during sexual activity that is new or worsening
• Urinary or bowel symptoms that persist without a clear explanation

Seeking medical advice early does not mean a diagnosis of cancer is likely, but it ensures that symptoms are assessed properly and managed without unnecessary delay.

Causes and Risk Factors for Vaginal Cancer

Vaginal cancer develops due to a combination of biological, lifestyle, and medical factors. While the exact cause is not always identifiable, certain conditions and exposures are known to increase the risk of developing this rare cancer.

Key causes and risk factors include:

• Persistent Human Papillomavirus (HPV) Infection: Long-standing infection with high-risk types of HPV is one of the most significant risk factors for vaginal cancer. HPV-related cellular changes can occur over time and may progress if not detected or managed early.
• Increasing Age: Vaginal cancer is more commonly diagnosed in older women, particularly after menopause. The risk increases with age, partly due to cumulative exposure to risk factors and age-related changes in vaginal tissue.
• History of Cervical Cancer or Precancerous Conditions: Women who have previously been treated for cervical cancer or high-grade cervical precancer may have a higher risk of developing vaginal cancer, underscoring the importance of long-term follow-up.
• Exposure to Diethylstilbestrol (DES): Women whose mothers were given DES during pregnancy, primarily between the 1940s and 1970s, have an increased risk of a rare form of vaginal adenocarcinoma.
• Smoking: Tobacco use weakens the immune system and reduces the body’s ability to clear HPV infections, indirectly increasing the risk of vaginal cancer.
• Weakened Immune System: Conditions or treatments that suppress the immune system, such as long-term immunosuppressive therapy or HIV infection, may raise the risk by allowing persistent viral infections and abnormal cell changes.

Understanding these risk factors can help identify women who may benefit from closer monitoring and timely gynaecological evaluation.

Vaginal Cancer in Different Age Groups

Vaginal cancer can affect women at different stages of life, but the risk profile, presentation, and clinical considerations may vary based on age and medical history. Understanding these differences helps improve awareness and supports timely evaluation.

Women aged 50-70 years

Vaginal cancer is most commonly diagnosed in this age group. Hormonal changes after menopause, combined with cumulative exposure to risk factors such as HPV infection or smoking, may contribute to higher incidence. Symptoms such as abnormal bleeding or persistent discharge in this age group should always be evaluated promptly.

Postmenopausal women

In postmenopausal women, vaginal bleeding is never considered normal and warrants medical attention. Because routine gynaecological symptoms may be attributed to ageing or vaginal dryness, there is a risk of delayed diagnosis if changes are overlooked. Awareness and timely reporting of symptoms are especially important in this group.

Younger Women (under 40 years)

Vaginal cancer is rare in younger women, but it can occur, particularly in association with persistent high-risk HPV infection or, less commonly, a history of DES exposure. Symptoms in younger women may be mistaken for infections or hormonal issues, which can delay further investigation.

Women with a History of Gynaecological Cancer or Precancer

Women who have previously been treated for cervical cancer or high-grade cervical precancer are at an increased risk of developing vaginal cancer. Long-term follow-up and regular gynaecological assessments are essential in this group to detect any abnormal changes early.

Recognising how vaginal cancer risk and presentation differ across age groups can help women and healthcare providers remain vigilant and seek timely evaluation when symptoms arise.

Stages and Stage-Based Management of Vaginal Cancer

Staging describes how far vaginal cancer has progressed at the time of diagnosis and helps guide treatment planning. It reflects the size of the tumour, whether nearby tissues are involved, and if the disease has spread beyond the vagina. Management strategies vary by stage, with treatment goals ranging from cure in early disease to symptom control and quality-of-life preservation in more advanced stages.

Early-Stage Vaginal Cancer

When vaginal cancer is detected at an early stage and remains limited to the vaginal tissue, treatment is often planned with curative intent. Management may involve localised treatment approaches aimed at removing or destroying the cancer while preserving surrounding structures and function. Care planning at this stage focuses on effective disease control with minimal long-term impact.

Locally Advanced Vaginal Cancer

Locally advanced disease involves spread to nearby tissues or structures within the pelvis. Treatment at this stage typically requires a carefully coordinated approach, often combining different treatment modalities to achieve better control of the disease. Decisions are guided by tumour location, extent of spread, and the patient’s overall health.

Advanced or Recurrent Vaginal Cancer

In advanced or recurrent vaginal cancer, where the disease has spread further or returned after initial treatment, management focuses on controlling disease progression, relieving symptoms, and maintaining quality of life. Treatment plans are individualised, taking into account previous treatments, tumour characteristics, and patient preferences. Supportive and palliative care are integrated as needed to address physical and emotional needs.

Staging allows doctors to tailor care appropriately and ensure that each patient receives treatment that aligns with the extent of disease and individual circumstances.

Supportive Care and Follow-Up

Supportive care is an integral part of vaginal cancer management and is provided alongside medical treatment at every stage of the disease. Its focus is on relieving symptoms, supporting physical and emotional wellbeing, and helping women maintain quality of life during and after treatment.

Supportive care may include:

• Symptom Management: Measures to relieve pain, discomfort, vaginal dryness, urinary or bowel symptoms, and treatment-related side effects, allowing women to remain as comfortable and active as possible.
• Emotional and Psychological Support: A diagnosis of vaginal cancer can have a significant emotional impact. Counselling and psychosocial support help women and their families cope with anxiety, stress, and changes in body image or sexual health.
• Sexual Health and Intimacy Support: Treatment may affect vaginal health and sexual function. Guidance and supportive interventions can help address concerns related to intimacy, comfort, and confidence in a sensitive and respectful manner.
• Rehabilitation and Recovery: Physical rehabilitation and guidance may be recommended to support recovery after treatment and improve overall strength and wellbeing.
• Long-Term Follow-Up Care: Regular follow-up visits are essential to monitor recovery, manage late effects of treatment, and detect any signs of recurrence early. Follow-up care also provides an opportunity to address ongoing symptoms and concerns.

A structured supportive care and follow-up plan ensures that women receive comprehensive care that extends beyond cancer treatment, addressing both physical health and overall wellbeing.

Why Choose RGCIRC for Vaginal Cancer Care

Vaginal cancer requires highly specialised evaluation and carefully coordinated treatment, given its rarity and the sensitive nature of care involved. Keeping that in mind, RGCIRC (Rajiv Gandhi Cancer Institute & Research Centre) offers a comprehensive and structured approach to gynaecologic cancer care, combining clinical expertise, advanced technology, and patient-centred support. Here’s why women across India trust RGCIRC for vaginal cancer care: 

Exclusive Focus on Cancer Care

As a centre dedicated entirely to oncology, RGCIRC brings focused expertise to the diagnosis and management of rare cancers such as vaginal cancer. This exclusive focus allows teams to stay aligned with evolving evidence and best practices in cancer care.

Multidisciplinary Tumour Board Approach

Each case is reviewed by a multidisciplinary tumour board involving gynaecologic oncologists, radiation oncologists, medical oncologists, radiologists, pathologists, and supportive care specialists. This collaborative approach ensures that treatment decisions are well-rounded, personalised, and aligned with the patient’s stage of disease and overall health.

Advanced Diagnostics and Precise Evaluation

Accurate diagnosis is critical in vaginal cancer. RGCIRC is equipped with advanced imaging, pathology, and diagnostic capabilities that support precise staging and treatment planning, helping guide appropriate and timely care.

Comprehensive Treatment and Supportive Services

From stage-based cancer treatment to rehabilitation, psychosocial support, and long-term follow-up, RGCIRC provides integrated care under one roof. This continuity helps reduce delays and ensures coordinated management throughout the treatment journey.

Ethical and Research-Driven Care

Care at RGCIRC is guided by evidence-based protocols, ethical practice, and transparency. Treatment recommendations prioritise medical necessity and patient wellbeing, with clear communication at every step of care.

This integrated, patient-focused model enables RGCIRC to deliver specialised and compassionate care for women diagnosed with vaginal cancer.

Preventive Measures and Women’s Health Awareness

Vaginal cancer cannot always be prevented, particularly in cases influenced by age or prior medical history. However, reducing exposure to known risk factors and maintaining regular gynaecological care can help lower risk and support earlier detection. Common preventive measures for vaginal cancer include: 

HPV Awareness and Prevention

Persistent infection with high-risk types of human papillomavirus (HPV) is a major risk factor for vaginal cancer. Awareness about HPV and its long-term effects on gynaecological health is important. HPV vaccination, where appropriate, plays a role in reducing the risk of HPV-related cancers, although it does not eliminate the need for routine medical evaluation.

Smoking Cessation

Smoking weakens the immune system and reduces the body’s ability to clear HPV infections, indirectly increasing cancer risk. Avoiding tobacco use supports overall gynaecological health and lowers the risk of several cancers.

Regular Gynaecological Evaluations

Routine gynaecological check-ups allow early identification of abnormal changes, especially in women with a history of cervical precancer, cervical cancer, or persistent HPV infection. Regular follow-up is particularly important for postmenopausal women and those at higher risk.

Early Reporting of Symptoms

Prompt medical evaluation of symptoms such as abnormal vaginal bleeding, unusual discharge, or persistent pelvic discomfort can lead to earlier diagnosis. Women should not dismiss these changes as normal ageing or minor concerns, especially when symptoms persist.

Ongoing Monitoring for High-Risk Women

Women with a history of gynaecological cancer, DES exposure, or immune suppression may require closer surveillance. Adhering to follow-up advice and recommended evaluations helps ensure timely detection of any concerning changes.

Preventive awareness, combined with regular medical care and attention to symptoms, plays a key role in supporting women’s health and improving outcomes in vaginal cancer.

Taking the Next Step Towards Specialised Vaginal Cancer Care

Vaginal cancer is rare, but early recognition of symptoms, awareness of risk factors, and timely medical evaluation can make a meaningful difference. With advances in diagnostics, stage-based treatment planning, and supportive care, women today have access to more precise and compassionate cancer care than ever before. Seeking expert guidance ensures that concerns are assessed accurately and care decisions are made with clarity and confidence.

To consult a cancer specialist at RGCIRC, call us at +91-11-47022222, +91 11 27051037

Frequently Asked Questions

Is vaginal cancer common?

Vaginal cancer is rare compared to other gynaecological cancers. Because of its low incidence, awareness is limited, which makes medical attention to persistent or unusual symptoms especially important.

Can vaginal cancer occur without noticeable symptoms?

Yes. In its early stages, vaginal cancer may not cause obvious symptoms. This lack of early signs can delay diagnosis, which is why persistent or unexplained vaginal changes should be evaluated.

What does vaginal cancer look like?

Vaginal cancer may not be visible externally. When present, it can appear as an abnormal area, lump, or sore inside the vagina, usually identified during a gynaecological examination rather than by self-inspection.

Is vaginal cancer found during routine gynaecological exams?

In some cases, abnormal vaginal changes may be detected during a pelvic examination. However, vaginal cancer is rare and not always identified through routine screening alone, making symptom awareness important.

Can vaginal cancer be detected early?

Early detection is possible but can be challenging, as symptoms may be mild or absent initially. Prompt evaluation of abnormal bleeding, discharge, or pelvic discomfort improves the chances of early diagnosis.

Is vaginal cancer painful?

Vaginal cancer may not cause pain in its early stages. Pain or discomfort can occur as the disease progresses, but effective pain management and supportive care are available.

Is vaginal cancer curable if detected early?

Yes. Vaginal cancer can often be treated effectively when diagnosed at an early stage. Outcomes depend on the stage of disease, tumour type, and the woman’s overall health.

Is vaginal cancer related to HPV infection?

Many cases of vaginal cancer are linked to long-term infection with high-risk types of human papillomavirus (HPV), although not all vaginal cancers are HPV-related.

Can younger women develop vaginal cancer?

Vaginal cancer is uncommon in younger women, but it can occur, particularly in those with persistent HPV infection or certain medical risk factors. Any unusual vaginal symptoms should be evaluated regardless of age.

Can vaginal cancer be prevented completely?

Vaginal cancer cannot always be prevented. However, reducing known risk factors, maintaining regular gynaecological care, and addressing abnormal symptoms early can help lower risk and support earlier detection.